A Clinical Trial of TQH3906 Capsules in Healthy Volunteers
Status:
COMPLETED
Trial end date:
2025-04-27
Target enrollment:
Participant gender:
Summary
This study was divided into three parts: single and multiple dosing and food effect study, which were designed to evaluate the safety and tolerability of TQH3906 capsules administered in single or multiple dose escalation in healthy adult subjects.
Phase:
PHASE1
Details
Lead Sponsor:
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.